Telemonitoring Devices for People with Heart Failure
Tests telemonitoring devices to help adjust heart failure medicines in adults aged 21 and older.
Plain-language title generated from the registry record
Registry title: Heart Failure Precision Medicine Study
Key facts
- Where
- Sacramento, United StatesSee the site
Where in United States
- UC Davis Medical CenterSacramento, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of California, Davis
- Trial code
- NCT04196842
- Record updated
- 9 February 2026
- Original description
The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.Read full original descriptionShow less
Heart Failure Precision Medicine Study
The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.
Inclusion: Diagnosis of Heart failure; Objective evidence of cardiac abnormality of structure or function (abnormal ECHO) or elevated levels of B-type natriuretic peptide (>100 pg/ml); HF stage B-D and class I-IV.
Exclusion: History of HTx; Patients unable to consent; Inability to comply with the protocol and follow-up requirements; Patients unable to use a smartphone; Patients assessed irregularly (less than two visits in one year); Use of Mechanical circulatory support device (MCSD); Comorbidities that, according to the PI, have the potential to interfere with the interpretation of the results.